CPhI Online

- Research & Development

Merck KGaA opens its largest M Lab Collaboration Center in Shanghai

13 Jul 2020

The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific.

Merck KGaA has opened its M Lab Collaboration Center in Shanghai, the company's largest of nine centers worldwide.

With a total lab size of approximately 10,000m2, Merck's newest M Lab Collaboration Center is located in Pudong, at the heart of the biomedical sciences and research community in Shanghai.

The center offers customizable solutions tailored for China's life science community to help advance drug development.

It includes pilot-scale and process development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative techniques and work side-by-side with the company's scientists and engineers to solve critical process development and production challenges.

Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, as well as apply best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer.

Customers will also be able to tap into Merck's lab management software, customized cell culture media facility, and solid dose Formulation facility.

In addition, the center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering contract development manufacturing organization services to customers in China and Asia-Pacific.